Side-by-side comparison of AI visibility scores, market position, and capabilities
Oracle Corporation's hospitality technology division; OPERA Cloud PMS for major hotel brands (Marriott/Hilton/Hyatt), MICROS restaurant POS — OPERA 5 to OPERA Cloud migration program as primary 2025 growth driver.
Oracle Hospitality is the hospitality technology business unit of Oracle Corporation (NYSE: ORCL) — providing cloud-based property management systems (PMS), point-of-sale systems, loyalty platforms, and distribution management solutions to hotels, resorts, cruise lines, casinos, and restaurants globally through the OPERA Cloud PMS platform and the MICROS F&B point-of-sale system. Oracle Hospitality serves the world's major hotel brands — Marriott, Hilton, Hyatt, IHG, Wyndham, and thousands of independent properties — with OPERA Cloud managing reservations, front desk check-in/check-out, room assignments, rate management, and guest profile data in a multi-property cloud platform that replaced the legacy on-premises OPERA 5 system. Oracle acquired Micros Systems (restaurant and hospitality POS) in 2014 for $5.3 billion and has operated the hospitality technology division as Oracle Hospitality since. Oracle Corporation named Clay Magouyrk and Mike Sicilia as co-CEOs in 2025 (replacing Safra Catz, who transitioned to executive vice chair), with Larry Ellison remaining as Chairman and CTO — a leadership transition that signals the next phase of Oracle's cloud infrastructure and AI strategy in which Oracle Hospitality's cloud-native property management platform benefits from Oracle Cloud Infrastructure (OCI) and Oracle's AI integration capabilities. The OPERA Cloud PMS migration (moving legacy hotel properties from on-premises OPERA 5 servers to Oracle's cloud-hosted OPERA Cloud) represents one of the largest hospitality industry digital transformation programs underway globally.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.